Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hematopoietic growth factors].

T Robak1

  • 1Pracownia Farmakologii Klinicznej Akademii Medycznej, Lodzi.

Postepy Higieny I Medycyny Doswiadczalnej
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

This review covers hematopoietic growth factors like interleukin-3 and GM-CSF, their role in blood cell development, and their therapeutic potential in hematologic disorders and leukemia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus.

ESMO open·2022
Same author

Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same author

Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial).

Leukemia·2017
Same author

appendix 6: Chronic lymphocytic leukaemia: eUpdate published online September 2016 (http://www.esmo.org/Guidelines/Haematological-Malignancies).

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Gene expression of INPP5F as an independent prognostic marker in fludarabine-based therapy of chronic lymphocytic leukemia.

Blood cancer journal·2015

Area of Science:

  • Hematology
  • Cell Biology
  • Immunology

Background:

  • Hematopoietic stem cells are crucial for blood cell production.
  • Cytokines play vital roles in regulating hematopoiesis.
  • Leukemia pathogenesis involves dysregulated cell proliferation and differentiation.

Purpose of the Study:

  • To review the roles of key hematopoietic growth factors.
  • To explore their involvement in blood cell development and leukemia.
  • To discuss therapeutic applications of recombinant growth factors.

Main Methods:

  • Literature review of scientific publications.
  • Analysis of the functions of specific cytokines.
  • Examination of clinical applications and potential.

Related Experiment Videos

Main Results:

  • Interleukin-3, GM-CSF, G-CSF, and M-CSF regulate hematopoietic cell proliferation and differentiation.
  • Erythropoietin and thrombopoietin are key in red blood cell and platelet development.
  • These factors show promise in treating myelodysplastic syndromes, AIDS, and other hematologic conditions.

Conclusions:

  • Hematopoietic growth factors are critical regulators of blood cell formation.
  • Dysregulation contributes to leukemia development.
  • Recombinant forms offer therapeutic potential for various hematologic and related disorders.